|
Friday, 17th February 2023, Day 2
|
|
Location:
Fairmont Doha
|
|
07:30am - 08:10am
|
Registration & Networking
|
|
08:10am - 08:20am
|
Chairman Welcome and Opening Remarks
|
|
08:20am - 08:30am
|
Co- Chair Welcome Remarks
|
|
Session 1: Learning from the Pandemic; Getting Ready for the Next
|
|
Moderators:
|
|
Chair: Dr. Hail M. Al-Abdely, MD (Saudi Arabia)
|
|
Co-Chair: Dr. Peter Valentine Coyle, Senior Consultant, HMC (Qatar)
|
|
08:30am - 08:55am
|
SARS-CoV-2 Evolution; What's Next?
Dr. Hadi Yaseen - Qatar University (Qatar)
|
|
08:55am - 09:20am
|
Pandemics: Past, Current and the Future
Dr. Faryal Khamis (Oman)
|
|
09:20am - 09:45am
|
Infectious Disease Research during Pandemic: Ethics, Challenges, Global Impact & Communication
Prof. Ziad Memish (Saudi Arabia)
|
|
09:45am - 10:00am
|
Panel Discussion (Q &A)
|
|
10:00am - 11:00am
|
Opening Ceremony & Special Recognition
|
| |
Moderator:
|
|
11:00am - 11:35am
|
Keynote Address: Global Perspective on Antimicrobial Resistance and Antimicrobial stewardship Program
|
|
Moderator:
Dr. Muna Al Maslamani - HMC (Qatar)
Dr. Yvan J-F. Hutin Director of the Department of Universal
Health Coverage, Communicable Diseases, WHO
|
|
11:35am - 12:45pm
|
Prayer, Networking & Lunch Break
|
|
Session 2: Resistance, Resistance, Resistance I
|
|
Moderators:
|
|
Chair: Dr. Jens
Thomsen, Abu Dhabi Public Health Authority, UAE
|
|
Co-Chair: Dr. Yaseer Al Deeb, Sr. Consultant Infectious Disease, HMC, Qatar
|
|
12:45pm - 01:10pm
|
Establishing Breakpoints for Resistance: Two Points of View CLSI and EUCAST Prospective
|
|
Dr. Walid Al-Wali - HMC (Qatar)
|
|
01:10pm - 01:35pm
|
Emerging Antimicrobial Resistance and the Role of the Novel Antibacterial Agents
|
|
Prof. Souha Kanj (Lebanon) Virtual
|
|
01:35pm - 02:00pm
|
Oral Therapy for Complex Bacterial Infections
|
|
Dr. Ali Omrani - HMC (Qatar)
|
|
02:00pm - 02:10pm
|
Panel Discussion (Q & A Session)
|
|
Session 3: Resistance, Resistance, Resistance II
|
|
Moderators:
|
|
Chair:
Dr Faraj Howady, Sr. Consultant Infectious Disease, HMC, Qatar
|
|
Co-Chair: Dr. Wadha Alfouzan, Consultant Microbiologist, Kuwait
|
|
02:10pm - 02:30pm
|
Will the Antifungals Work? Emerging Antifungal Resistance
Dr. Hail M. Al-Abdely, MD (Saudi Arabia)
|
|
02:30pm - 02:50pm
|
Current and future treatment Options for Drug-Resistant Mycobacterial Infections
Dr. Abdulrahman Alrajhi (Saudi Arabia)
|
|
02:50pm - 03:00pm
|
Panel Discussion (Q & A Session)
|
|
03:00pm - 03:20pm
|
Panel Discussion - Resistance in ICU Challenges and Solutions
|
|
Moderator: Dr. Hussam Al Soub, Sr. Consultant Infectious Disease, HMC, Qatar
|
|
Panel: Dr. Hani Walid Jaouni - Qatar, Prof Susu Zughaier - Qatar, Dr. Hamad Al Hadi - Qatar, Dr Arshad Chanda - Qatar
|
|
03:20pm - 03:45pm
|
Prayer, Networking & Coffee Break
|
|
Session 4: Integration of Infectious Disease with Quality
|
|
Moderators:
|
|
Chair: Dr. Reham Hassan, Qatar
|
|
Co-Chair: Dr. Muna Al Rashid, AED Quality and Patient Safety, CDC, Qatar
|
|
03:45pm - 03:55pm
|
Project 1 - Mental Health Assessment,
Dr. Waqar Munir - Qatar, Ms. Suni Latheef - Qatar
|
|
03:55pm - 04:05pm
|
Project 2 - Mono Resistant TB,
Dr. Maliha Thapur - Qatar, Mr. Thanveer - Qatar
|
|
04:05pm - 04:15pm
|
Project 3 - Video Assisted Dots,
Dr. Faraj Howady - Qatar, Mr. V jay - Qatar
|
|
Session 5: ID Grand Round
|
|
Moderators:
Dr. Muna Al Maslamani, Qatar
|
|
Panels:
Dr. Hussam Al-Soub - Qatar, Dr Abdulrahman Alrajhi - KSA,
Dr. Faryal Khamis - Oman, Dr. Jehad Saleh Abdallah - UAE
|
|
04:15pm - 04:30pm
|
Case 1 - Dr. Junais Koleri,
ID Fellow 3rd year - Qatar
|
|
04:30pm - 04:45pm
|
Case 2 - Dr. Sreethish Sasi,
ID Fellow 2nd year- Qatar
|
|
04:45pm - 05:00pm
|
Case 3 - Dr. Enas Walid,
ID Fellow 2nd year- Qatar
|
|
Session 6: Scientific Symposium
|
|
Moderators:
|
|
Chair: Dr. Mohd H M Alhajri, MOPH, Qatar
|
|
Co-Chair: Dr. Khalid Hamid Elawad Health Protection Manager Preventative Health, PHCC, Qatar
|
|
05:00pm - 05:20pm
|
Scientific Symposium - Meningococcal Vaccination in Adolescents
Dr. Faryal Khamis (Oman)
|
|
05:20pm - 05:40pm
|
Scientific Symposium - A Spotlight on the Importance of Antivirals in the COVID-19 Treatment Space
Dr. Luke Moore (UK)
|
|
05:40pm - 05:50pm
|
Closing Remakes - Day 01
|
